Pharmaceutical Technology-01-02-2008

Pharmaceutical Technology

Report from: India, January 2008

January 02, 2008

News

32

1

The $6.3 billion Indian pharmaceutical industry is at a crossroad. Aiming to be the international home for quality drugs, which could in itself propel India's market to $20 billion by 2015 according to recent estimates, the generic hothouse is clearly moving beyond its earlier low-cost mindset.

Singapore Attracts Pharmaceutical Manufacturing Investment

January 02, 2008

Online Exclusive

32

1

Singapore moves forward with a plan to diversify its life science investment with projects in biologics and drug discovery.

Coming Down the Pike: hES cells

January 02, 2008

News

32

1

The most significant early-stage discovery to hit the journals in late 2007 were the dual announcements from two independent research groups that they turned adult human skin cells into cells with properties that are seemingly identical with human embryonic stem (hES) cells.

Setting Cleaning Validation Acceptance Limits for Topical Formulations

January 02, 2008

Peer-Reviewed Research

32

1

There is a need for current cleaning validation methods to be used for topical formulations. The authors highlight the issues and challenges encountered.

How to Meet Regulatory Challenges in the New Year

January 02, 2008

Viewpoint

32

1

With 2007 projects wrapped up, or so we hope, forward-looking companies need to take their next step.

The Importance of Leachables and Extractables Testing for a Successful Product Launch

January 02, 2008

Online Exclusive

32

1

FDA’s May 1999 container-closure guidance has accelerated the requirements for extractable and leachable testing of container-closure packaging components. Since that date, additional recommendations have been made by industry groups to clarify how these issues should be addressed.

Manufacturing Investment in Puerto Rico

January 02, 2008

Special Report

32

1

Puerto Rico seeks to build its standing in biopharmaceutical manufacturing and research as it retains its role in bulk pharmaceutical and dosage manufacturing for small molecules.

How to Build a Better Outsourcing Relationship

January 02, 2008

Online Exclusive

32

1

What should contractors and their clients bear in mind when they collaborate on a project?

Assessing Hibiscus rosa-sinensis Linn as an Excipient in Sustained-Release Tablets

January 02, 2008

Peer-Reviewed Research

32

1

Natural gums and mucilage are biocompatible, cheap, readily available, and represent a potential source of excipients. The authors examine the functionality of mucilage extracted from the leaves of Hibiscus rosa-sinensis Linn as an excipient in a sustained-release tablet formulation.

Trash and Treasures

January 02, 2008

Agent-In-Place

32

1

Process efficiency is measured not only by what is kept, but also by what is thrown away.